XTT Cytotoxicity
1. Biological Effect: Cytotoxicity Tests
2. Turnaround time: 4 weeks
3. Sample Requirements:
ISO
120 cm² (test item < 0.5 mm thick);
60 cm² (test item ≥ 0.5 mm thick);
4 grams;
5 ml;
ISO 10993-5
The purpose of the study is to determine the potential biological reactivity of a mammalian cell culture (L929 cell line) in response to the medical device extract. The test item is extracted in MEM with 10% FBS (Fetal Bovine Serum) for usually 24 hours at 37 °C or 72 hours at 37 °C (permanent implants or prolonged exposure medical device). The cells are allowed to grow to sub-confluency in tissue culture plates and exposed to the test item extract at least 4 concentrations (100% always included) in 6 replicates. The plates are incubated for 24 hours at 37 °C after which the viability is assessed via the reduction of the yellow water-soluble XTT by the mitochondrial reductases enzymes into orange water-soluble formazan. The number of viable cells correlates to the color intensity determined by photometric measurements. The medical device is considered non-cytotoxic if the percentage of viable cells is equal to or greater than 70% of the untreated control.
How We Work
Discovery & Insight
We begin with an in-depth consultation to understand your needs, challenges, and objectives. This helps us define the right strategy and scientific approach for your project.
Design & Development
Our experts translate your vision into actionable plans — combining innovative research, data, and technology to build precise and reliable solutions.
Delivery & Support
We implement the solution with full transparency and ongoing communication. After delivery, we stay involved — supporting you with optimization, updates, and future improvements.
Contact with us
We’re open to collaboration and research partnerships. Fill out the form — our team will respond as soon as possible.
Location:
Europejski Instytut Biomedyczny sp. z o.o.
ul. Bartycka 63A lok. 6, 00-716 Warszawa
Mail:
contact@ebi.bio
Phone:
+48 22 780 06 32
Get in touch